Rocket Lab Navigates Funding Boost and Development Hurdle

Rocket Lab CEO cuts salary to $1 as order backlog hits $1.85B, but a technical failure delays the Neutron rocket launch to late 2026, creating a mixed outlook.

The space technology firm Rocket Lab USA finds itself at a critical juncture, marked by a significant capital raise and a concurrent technical setback in its flagship rocket program. These developments present a complex picture for investors, blending strong operational performance with new engineering challenges.

CEO's Symbolic Move and Robust Order Book

In a notable gesture, founder and Chief Executive Peter Beck has reduced his annual base salary to one dollar and has forfeited all unvested stock options, valued in the millions. The capital freed by this move is being channeled directly into the company's strategic research and development initiatives.

Operationally, the business shows considerable momentum. Rocket Lab's backlog of orders surged by 73% year-over-year to reach $1.85 billion. This strength was recently underscored by a new $190 million contract with the U.S. Department of Defense for 20 hypersonic test missions. Market reaction to the week's news was positive, with the company's equity closing Friday's session at $67.73, representing a gain of over 11% for the week.

Billion-Dollar Facility and a Technical Delay

To fund long-term growth initiatives and potential acquisitions, the company has established a new at-the-market equity offering program. This facility, authorized to raise up to $1 billion, replaces an older arrangement and is intended to bolster financial resources for upcoming defense and space missions.

However, the associated prospectus filing revealed an unexpected complication. During a qualification test in January, a tank for the new, larger Neutron rocket experienced a failure. This incident has pushed the inaugural launch timeline for this key vehicle into the fourth quarter of 2026.

Divergent Views from Market Experts

The mix of operational tailwinds and technical delays has resulted in a split among analysts covering the stock:

• Wells Fargo: Initiated coverage with an "Equal Weight" rating and a $60 price target.
• Roth MKM: Reiterated a "Buy" recommendation, setting a $90 price target, driven by confidence in the growing satellite business.

Rocket Lab reported revenue of $602 million for the completed fiscal year 2025, establishing a solid foundation. To achieve its stated goal of reaching profitability by 2027, the company must now demonstrate it can swiftly overcome the technical hurdles in the Neutron program while efficiently executing on its substantial order backlog.